Green's Child and Adolescent Clinical Psychopharmacology

87,36 € 84,00 €
Disponible
ISBN
9781451107142
Edición
Autores
Rick Bowers, William M. Klykylo
Editorial
Lippincott Williams & Wilkins
Fecha Publicacion
26 oct. 2013
Características
The ideal quick reference for the busy mental health clinician seeing younger patients, the Fifth Edition of Green’s Child and Adolescent Clinical Psychopathology has been fully revised by a new team of authors active in clinical practice and resident education. A trusted reference in the field, Green’s continues to provide practical and balanced information on the full range of medications used to treat mental health disorders in children and adolescents. This rapid reference delivers… • Detailed coverage of medication usage—including both FDA-approved and evidence-based off-label uses. • Precautions and warnings help readers avoid prescribing errors and adverse drug interactions. • Emphasis on recent and highly used medications, with older and less often used agents grouped in an Appendix. • Convenient, reader-friendly organization makes essential information easy to find and use. NEW to the Fifth Edition… • Increased focus on medication effects and cost-effectiveness • New information on cardiac function and risk factors in patients taking stimulants • Long-term suicide risks associated with SSRIs • Longer term outcomes of major depression treatment • Use of anticonvulsant medications in patients with bipolar disorder • Weight gain in patients taking antipsychotics
The ideal quick reference for the busy mental health clinician seeing younger patients, the Fifth Edition of Green’s Child and Adolescent Clinical Psychopathology has been fully revised by a new team of authors active in clinical practice and resident education. A trusted reference in the field, Green’s continues to provide practical and balanced information on the full range of medications used to treat mental health disorders in children and adolescents. This rapid reference delivers… • Detailed coverage of medication usage—including both FDA-approved and evidence-based off-label uses. • Precautions and warnings help readers avoid prescribing errors and adverse drug interactions. • Emphasis on recent and highly used medications, with older and less often used agents grouped in an Appendix. • Convenient, reader-friendly organization makes essential information easy to find and use. NEW to the Fifth Edition… • Increased focus on medication effects and cost-effectiveness • New information on cardiac function and risk factors in patients taking stimulants • Long-term suicide risks associated with SSRIs • Longer term outcomes of major depression treatment • Use of anticonvulsant medications in patients with bipolar disorder • Weight gain in patients taking antipsychotics
Escribir Su propia reseña
Solo usuarios registrados pueden escribir comentarios. Por favor, iniciar sesión o crear una cuenta